Regenxbio Inc (RGNX)

Deferred Revenue

$9.88M

Quarterly · Period ending: · USD

RGNX logo

RGNX Deferred Revenue

Latest reported$9.88M
RGNX Quarterly Deferred Revenue ($0.00 → $9.88M)
High-resolution chart · PNG

RGNX deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regenxbio Inc Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
9,882,000
5,919,000
10,452,000
13,195,000
13,977,000
13,588,000
115,000
144,000
21,000
13,000
148,000
442,000
448,000
1,311,000
1,829,000
5,903,000
6,636,000
3,333,000
3,333,000
395,000
395,000
395,000
449,000
449,000
450,000
0
0
3,333,000
3,333,000
600,000
600,000
600,000
600,000
0
0
0
0
0
0
0
0
35,000
127,000
127,000
132,000
0
153,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.